Product Information
GS ESOMEPRAZOLE MAG DR 20 MG is a generic product labeled by L. Perrigo Company, priced at $0.3460 per EA under NDC 00113089802. Its NADAC has been published 378 times since Jul 10, 2019.
FDA first approved this application on Aug 18, 2017.
Strength
20 mg/1
Manufacturer
L. Perrigo CompanyNDC
00113089802
Classification
Generic
Dosage Form
CAPSULE, DELAYED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ESOMEPRAZOLEApproval Type
Generic (ANDA)
FDA Application
ANDA207193FDA Approved
8/18/2017
On Market Since
9/22/2017
Pharmacological Classes
Price Statistics
The NADAC for GS ESOMEPRAZOLE MAG DR 20 MG has been published 378 times since Jul 10, 2019, and over the history we have for it it has declined 7.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3460 per EA |
|---|---|
| All-time high | $0.3752 (Feb 15, 2023) |
| All-time low | $0.2771 (Sep 18, 2019) |
| 52-week high | $0.3599 |
| 52-week low | $0.3454 |
| Median price | $0.3465 |
| Average price | $0.3454 |
| Largest weekly change | -16.6% (Sep 18, 2019) |
| Weeks tracked | 378 |
| Tracking since | Jul 10, 2019 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
L. Perrigo Company manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Esomeprazole market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Proton Pump Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of GS ESOMEPRAZOLE MAG DR 20 MG?
The current National Average Drug Acquisition Cost (NADAC) for GS ESOMEPRAZOLE MAG DR 20 MG, manufactured by L. Perrigo Company, is $0.3460 per EA (NDC 00113089802), effective Sep 30, 2026.
How has the price of GS ESOMEPRAZOLE MAG DR 20 MG changed over time?
Over the history we have for it, the NADAC for GS ESOMEPRAZOLE MAG DR 20 MG has declined 7.7%. It has been tracked across 378 weekly CMS publications since Jul 10, 2019.
What are the highest and lowest recorded NADAC prices for GS ESOMEPRAZOLE MAG DR 20 MG?
Since Jul 10, 2019, the NADAC for GS ESOMEPRAZOLE MAG DR 20 MG has ranged from a low of $0.2771 (Sep 18, 2019) to a high of $0.3752 (Feb 15, 2023), with a median of $0.3465 per EA.
Are there cheaper alternatives to GS ESOMEPRAZOLE MAG DR 20 MG?
4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as GS ESOMEPRAZOLE MAG DR 20 MG in a comparable dosage form, but none are currently priced below it.
Who manufactures GS ESOMEPRAZOLE MAG DR 20 MG?
GS ESOMEPRAZOLE MAG DR 20 MG (NDC 00113089802) is labeled by L. Perrigo Company, and CMS classifies it as a generic product.